STUCCI, LUIGIA STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 2.708
EU - Europa 593
AS - Asia 378
OC - Oceania 2
SA - Sud America 1
Totale 3.682
Nazione #
US - Stati Uniti d'America 2.695
CN - Cina 197
SE - Svezia 185
SG - Singapore 130
IT - Italia 115
GB - Regno Unito 61
DE - Germania 50
FI - Finlandia 40
RU - Federazione Russa 32
UA - Ucraina 25
FR - Francia 21
BE - Belgio 20
VN - Vietnam 16
CA - Canada 13
IN - India 12
NL - Olanda 10
IE - Irlanda 9
HK - Hong Kong 7
TR - Turchia 5
GR - Grecia 4
LT - Lituania 4
AL - Albania 3
AT - Austria 3
KR - Corea 3
AU - Australia 2
CZ - Repubblica Ceca 2
ES - Italia 2
HU - Ungheria 2
IR - Iran 2
MY - Malesia 2
RO - Romania 2
AM - Armenia 1
BD - Bangladesh 1
HR - Croazia 1
ID - Indonesia 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
Totale 3.682
Città #
Fairfield 373
Woodbridge 318
Chandler 301
Ashburn 203
Houston 177
Nyköping 159
Seattle 158
Cambridge 149
Wilmington 126
Ann Arbor 116
Singapore 104
Jacksonville 73
Beijing 63
Lawrence 49
Roxbury 47
Nanjing 46
New York 34
Des Moines 32
Bari 30
Inglewood 27
Princeton 22
Brussels 20
Helsinki 19
San Diego 18
Dong Ket 16
Brooklyn 15
Los Angeles 14
Paris 13
Redwood City 13
Boardman 12
Munich 10
Dearborn 9
Dublin 9
London 9
Nanchang 9
Santa Clara 9
Washington 9
Hebei 8
Ottawa 8
Tianjin 7
San Mateo 6
Shenyang 6
Augusta 5
Bologna 4
Changsha 4
Edinburgh 4
Iowa City 4
Monmouth Junction 4
Phoenix 4
Shanghai 4
Taranto 4
Amsterdam 3
Chiswick 3
Frankfurt am Main 3
Guangzhou 3
Hounslow 3
Marseille 3
New Delhi 3
Norwalk 3
Pune 3
Toronto 3
Vienna 3
Albany 2
Brno 2
Brugherio 2
Canberra 2
Catania 2
Cutrofiano 2
Diyarbakır 2
Grumo Appula 2
Hangzhou 2
Hefei 2
Hyderabad 2
Islington 2
Jiaxing 2
Jinan 2
Kilburn 2
Konya 2
Kowloon City 2
Kuala Lumpur 2
Lanzhou 2
Milan 2
Moscow 2
Napoli 2
New Bedfont 2
Noicattaro 2
Redmond 2
Rome 2
Shenzhen 2
Sopron 2
Suwon 2
Taizhou 2
Terlizzi 2
Wernigerode 2
Xian 2
Alatri 1
Arcugnano 1
Ardabil 1
Assèmini 1
Baotou 1
Totale 2.987
Nome #
null 149
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 131
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 127
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 120
Adenocarcinoma of the ceruminous glands: role of the VMAT 111
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 107
Avβ3 integrin: Pathogenetic role in osteotropic tumors 106
Does cilengitide deserve another chance? 105
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 105
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 103
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 103
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition 103
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 98
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 95
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 93
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 88
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 87
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 85
Double heterozygosity for BRCA1 pathogenic variant and BRCA2 polymorphic stop codon K3326X: A case report in a southern Italian family 84
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 82
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 81
The immune escape in melanoma: role of the impaired dendritic cell function 78
null 78
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 77
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 75
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 75
Reframing Breast Cancer Experience through Metaphors: A New Operative System to Enhance Patients’ Healing Process 74
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management 71
Current status and perspectives in immunotherapy for metastatic melanoma 71
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 70
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 67
null 66
null 62
Dietary compounds and cutaneous malignant melanoma: Recent advances from a biological perspective 59
COVID 19: HEALTH, STATISTICAL AND CONSTITUTIONAL ASPECTS 59
null 57
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 56
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 55
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 54
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 51
miRNAs in melanoma: a defined role in tumor progression and metastasis 50
[Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease]. FT Alla ricerca di nuovi marcatori in osteo-oncologia: la fosfatasi acida tartrato-resistente nella malattia ossea mielomatosa 46
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 42
A large metastatic intramammary lesion of an occult melanoma 41
Effect of age on melanoma risk, prognosis and treatment response 41
Characterization of the metastatic behavior and gene expression profile (RNAseq) of different melanoma cell lines: a comprehensive in vivo model. 41
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice 38
null 33
Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: A potential role as additional prognostic marker 31
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma. 23
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice 23
Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence? 21
Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: a potential role as additional prognostic marker. 20
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 14
Non-Melanoma Skin Cancers: Biological and Clinical Features 10
Te avbeta3/avbeta5 blockage by Cilengitide disables the osteoclast-like differentiation of malignant plasma cells in multiple myeloma 8
Does clilengitide deserve another chance? 6
Totale 3.906
Categoria #
all - tutte 18.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020505 0 0 0 0 0 57 76 80 92 76 93 31
2020/2021776 46 103 73 91 66 68 62 45 38 72 60 52
2021/2022374 18 21 5 17 15 38 9 20 32 37 63 99
2022/2023727 106 98 46 70 69 100 14 85 107 7 15 10
2023/2024310 16 49 18 51 30 66 11 20 8 4 3 34
2024/2025320 37 14 98 60 40 71 0 0 0 0 0 0
Totale 3.906